Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

Authors: Peter A. Campochiaro, Robert L. Avery, David M. Brown, Jeffrey S. Heier, Allen C. Ho, Stephen Huddleston, Glenn J. Jaffe, Arshad M. Khanani, Stephen Pakola, Dante J. Pieramici, Charles C. Wykoff, Sherri Van Everen - The Lancet 2024 cited by 119